文献速递垂体与肾上腺疾病

动态试验鉴别诊断促肾上腺皮质激素依赖性库欣综合征:系统评价与Meta分析

Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review and Meta-analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该系统评价与Meta分析检索1990至2021年文献,纳入62项研究,评估促肾上腺皮质激素释放激素(CRH)试验、去氨加压素试验及大剂量地塞米松抑制试验(HDDST)鉴别库欣病(CD)与异位促肾上腺皮质激素分泌(EAS)的诊断准确性。结果显示CRH试验检测CD的敏感性和检测EAS的特异性最高,诊断比值比为58(95%CI 43.25-77.47),曲线下面积为0.934。作者认为CRH试验后ACTH阳性的患者极可能为CD,需进一步研究动态试验联合影像的作用。

要点

  • CRH试验检测CD的敏感性:ACTH为86.9%(95%CI 82.1-90.6),皮质醇为86.2%(95%CI 78.3-91.5)。
  • CRH试验检测EAS的特异性:ACTH为93.9%(95%CI 87-98.3),皮质醇为89.4%(95%CI 82.8-93.7)。
  • HDDST和去氨加压素试验的诊断准确性低于CRH试验。

核心结论

  • Meta分析表明,CRH试验后ACTH反应阳性的患者极可能为库欣病(CD)。
  • 需要进一步研究分析动态试验联合影像的作用。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、OVID和Web of Science数据库1990至2021年发表的文献。
  • 纳入至少描述1种试验(CRH试验、去氨加压素试验或HDDST)及用于确立CD或EAS诊断的诊断参考标准(组织病理学、岩下窦采样、手术缓解、影像学和长期随访)的文章。
  • 共纳入62项研究:43项报告HDDST,32项报告CRH试验,21项报告去氨加压素试验。

主要发现

  • CRH试验检测CD的敏感性最高:ACTH为86.9%(95%CI 82.1-90.6),皮质醇为86.2%(95%CI 78.3-91.5)。
  • CRH试验检测EAS的特异性最高:ACTH为93.9%(95%CI 87-98.3),皮质醇为89.4%(95%CI 82.8-93.7)。
  • CRH试验的诊断比值比为58(95%CI 43.25-77.47),曲线下面积大,受试者工作特征为0.934。
  • HDDST和去氨加压素试验的诊断准确性低于CRH试验。

关键数值与推荐

  • CRH试验检测CD的敏感性:ACTH 86.9%(95%CI 82.1-90.6),皮质醇86.2%(95%CI 78.3-91.5)。
  • CRH试验检测EAS的特异性:ACTH 93.9%(95%CI 87-98.3),皮质醇89.4%(95%CI 82.8-93.7)。
  • CRH试验的诊断比值比为58(95%CI 43.25-77.47),受试者工作特征曲线下面积为0.934。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究分析动态试验联合影像的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Diagnostic accuracy of testing currently used for the differential diagnosis of Cushing disease (CD) vs ectopic adrenocorticotropic hormone secretion (EAS) is difficult to interpret. OBJECTIVE: The present study aimed to identify and evaluate the diagnostic accuracy of the corticotropin-releasing hormone (CRH) test, the desmopressin test, and the high-dose dexamethasone suppression test (HDDST) when used to establish a CD or EAS diagnosis. METHODS: This study is a systematic review of the literature and meta-analysis. MEDLINE, OVID, and Web of Science databases were searched for articles published between 1990 and 2021. Articles included described at least 1 test(s) (CRH, desmopressin, or HDDST) and the diagnostic reference standard(s) (histopathology, petrosal sinus sampling, surgical remission, imaging, and long-term follow-up) used to establish a CD or EAS diagnosis. RESULTS: Sixty-two studies were included: 43 reported the use of the HDDST; 32, the CRH test; and the 21, the desmopressin test. The CRH test was found to have the highest sensitivity in detecting CD (ACTH 86.9%, 95% CI 82.1-90.6, cortisol 86.2%, 95% CI 78.3-91.5) and the highest specificity in detecting EAS (ACTH 93.9%, 95% CI 87-98.3, cortisol 89.4%, 95% CI 82.8-93.7). This resulted in a high diagnostic odds ratio (58, 95% CI 43.25-77.47), large area under the curve, and a receiver operating characteristic of 0.934. The diagnostic accuracy of the HDDST and desmopressin test was lower than that of the CRH test. CONCLUSION: The meta-analysis indicates that a patient with a positive ACTH response after a CRH test is highly likely to have CD. Further studies analyzing role of dynamic testing in addition to imaging are needed.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ceccato F, Barbot M, Mondin A, et al. Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2023. PMID: 36453141. doi:10.1210/clinem/dgac686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。